Keros Therapeutics (KROS) Total Liabilities (2019 - 2026)
Keros Therapeutics (KROS) reported Total Liabilities of $25.28 million for Q2 2026, down 49.9% from $50.43 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Total Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics posted Total Liabilities of $34.89 million, down 21.3% from FY2024.
- Total Liabilities has a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
- By year, Total Liabilities came in at $44.33 million in FY2024 (+17.2%), $37.81 million in FY2023 (+28.8%), $29.36 million in FY2022 (+143.1%) and $12.08 million in FY2021 (+56.4%).
- The Q2 2026 figure ranks as the lowest quarterly Total Liabilities since Q3 2022.
- Year over year, Total Liabilities gained in four of the last seven quarters, with growth averaging 15.1%.
- The high point for year-over-year Total Liabilities in five years was Q3 2023 (growth of 163.8%); the low point was Q2 2026 (a decline of 49.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Keros Therapeutics | 226.12 Mn | -1.70 Bn | - | 25.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.28 Mn |
| Dec 31, 2025 | 34.89 Mn |
| Sep 30, 2025 | 39.20 Mn |
| Jun 30, 2025 | 50.43 Mn |
| Mar 31, 2025 | 55.69 Mn |
| Dec 31, 2024 | 44.33 Mn |
| Sep 30, 2024 | 46.44 Mn |
| Jun 30, 2024 | 34.11 Mn |
| Mar 31, 2024 | 31.87 Mn |
| Dec 31, 2023 | 37.81 Mn |
| Sep 30, 2023 | 30.41 Mn |
| Jun 30, 2023 | 30.05 Mn |
| Mar 31, 2023 | 29.45 Mn |
| Dec 31, 2022 | 29.36 Mn |
| Sep 30, 2022 | 11.53 Mn |
| Jun 30, 2022 | 15.45 Mn |
| Mar 31, 2022 | 11.65 Mn |
| Dec 31, 2021 | 12.08 Mn |
| Sep 30, 2021 | 11.48 Mn |
| Jun 30, 2021 | 7.81 Mn |
API Access
Keros Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();